GB9013410D0 - Polypeptide and its use - Google Patents

Polypeptide and its use

Info

Publication number
GB9013410D0
GB9013410D0 GB909013410A GB9013410A GB9013410D0 GB 9013410 D0 GB9013410 D0 GB 9013410D0 GB 909013410 A GB909013410 A GB 909013410A GB 9013410 A GB9013410 A GB 9013410A GB 9013410 D0 GB9013410 D0 GB 9013410D0
Authority
GB
United Kingdom
Prior art keywords
polypeptide
use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB909013410A
Other versions
GB2246569A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHARING CROSS SUNLEY RESEARCH
CHARING CROSS SUNLEY RESEARCH CENTRE
Original Assignee
CHARING CROSS SUNLEY RESEARCH
CHARING CROSS SUNLEY RESEARCH, THE CENTRE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHARING CROSS SUNLEY RESEARCH, CHARING CROSS SUNLEY RESEARCH, THE CENTRE filed Critical CHARING CROSS SUNLEY RESEARCH
Priority to GB9013410A priority Critical patent/GB2246569A/en
Publication of GB9013410D0 publication Critical patent/GB9013410D0/en
Publication of GB2246569A publication Critical patent/GB2246569A/en
Application status is Withdrawn legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
GB9013410A 1990-06-15 1990-06-15 Tumour necrosis factor - alpha binding protein Withdrawn GB2246569A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9013410A GB2246569A (en) 1990-06-15 1990-06-15 Tumour necrosis factor - alpha binding protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9013410A GB2246569A (en) 1990-06-15 1990-06-15 Tumour necrosis factor - alpha binding protein

Publications (2)

Publication Number Publication Date
GB9013410D0 true GB9013410D0 (en) 1990-08-08
GB2246569A GB2246569A (en) 1992-02-05

Family

ID=10677692

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9013410A Withdrawn GB2246569A (en) 1990-06-15 1990-06-15 Tumour necrosis factor - alpha binding protein

Country Status (1)

Country Link
GB (1) GB2246569A (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512544A (en) * 1987-09-13 1996-04-30 Yeda Research And Development Co. Ltd. Pharmaceutical compositions comprising an anticytokine
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
US7264944B1 (en) 1989-04-21 2007-09-04 Amgen Inc. TNF receptors, TNF binding proteins and DNAs coding for them
US6221675B1 (en) 1989-04-21 2001-04-24 Amgen, Inc. TNF receptors, TNF binding proteins and DNAs coding for them
AT289350T (en) * 1989-04-21 2005-03-15 Amgen Inc Tnf-receptor, tnf binding proteins and encoding it dnas
US6143866A (en) * 1989-07-18 2000-11-07 Amgen, Inc. Tumor necrosis factor (TNF) inhibitor and method for obtaining the same
IL95031A (en) 1989-07-18 2007-03-08 Amgen Inc Method for the production of a human recombinant tumor necrosis factor inhibitor
DK0939121T4 (en) 1989-09-12 2008-02-04 Ahp Mfg B V TNF binding proteins
IL98078D0 (en) * 1991-05-07 1992-06-21 Yeda Res & Dev Pharmaceutical compositions comprising an anticytokyne
WO1993006128A1 (en) * 1991-09-16 1993-04-01 Peptide Technology Limited Tnf antagonist peptides
US6270766B1 (en) 1992-10-08 2001-08-07 The Kennedy Institute Of Rheumatology Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
TW555765B (en) 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
WO1998024477A1 (en) 1996-12-06 1998-06-11 Amgen Inc. Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
AU5696198A (en) 1996-12-06 1998-06-29 Amgen, Inc. Combination therapy using a tnf binding protein for treating tnf-mediated diseases
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
PL222211B1 (en) 2001-06-26 2016-07-29 Amgen Fremont Inc. Antibodies to opgl
US9028822B2 (en) 2002-06-28 2015-05-12 Domantis Limited Antagonists against TNFR1 and methods of use therefor
WO2003011323A1 (en) * 2001-07-30 2003-02-13 Genset S.A. Agonists and antagonists of contabix for use in the treatment of metabolic disorders
WO2004060911A2 (en) 2002-12-30 2004-07-22 Amgen Inc. Combination therapy with co-stimulatory factors
US7833527B2 (en) 2006-10-02 2010-11-16 Amgen Inc. Methods of treating psoriasis using IL-17 Receptor A antibodies
TW201117824A (en) 2009-10-12 2011-06-01 Amgen Inc Use of IL-17 receptor a antigen binding proteins
WO2013016220A1 (en) 2011-07-22 2013-01-31 Amgen Inc. Il-17 receptor a is required for il-17c biology
AU2015241373A1 (en) 2014-03-31 2016-10-06 Amgen K-A, Inc. Methods of treating nail and scalp psoriasis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT289350T (en) * 1989-04-21 2005-03-15 Amgen Inc Tnf-receptor, tnf binding proteins and encoding it dnas
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
AU642938B2 (en) * 1989-12-13 1993-11-04 Yeda Research And Development Co. Ltd. Expression of the recombinant tumor necrosis factor binding protein 1 (TBP-1)

Also Published As

Publication number Publication date
GB2246569A (en) 1992-02-05

Similar Documents

Publication Publication Date Title
GB2274268B (en) Labels and manufacture thereof
GB2252771B (en) Platinum complexes and use thereof
GB2247942B (en) Cryostat
GB2252322B (en) Phosphonated oligomers and uses thereof
HU9203338D0 (en) Preparatives equivalent with skin
IL101690D0 (en) Antibodies and methods utilizing the same
HK1000103A1 (en) Oxime-carbamates and oxime-carbonates as broncodilators and anti-inflammatory agents
HU9501329D0 (en) Novel 3,3-diphenylpropylamines, their use and preparation
EP0472722A4 (en) Plant desaturases - compositions and uses
HU904853D0 (en) Enzymes and their use
IE911670A1 (en) Highly reflective biogratings and method
SG47033A1 (en) Film-enrobed unitary-core medicament and the like
SK114999A3 (en) 7-nitro-9-substituted amino-6-demethyl-6-deoxytetracyclines and methods for making the same
IL95584D0 (en) Indole-,benzofuran-,and benzothiophene-containing lipoxygenase-inhibiting compounds
GR3019343T3 (en) Latency associated peptide and uses therefor
NZ247205A (en) Intermediate compounds: 4-ethyl-5-fluoropyrimidine and 4-chloro-6-ethyl-5-fluoropyrimidine
CZ9501756A3 (en) Composition and the use thereof
PH27053A (en) Pesticidal-2-cyano-5-alkoxy-1-arylpyrazoles compositions and use
HK1013847A1 (en) Gdf-1 and uog-1 proteins
IE872929L (en) Nor-statine and nor-cyclostatine polypeptides
HU211904A9 (en) Peptide compound and its preparation
CS9200356A3 (en) Novel beta-amino-alpha-hydroxycarboxylic acids and pharmaceuticalcompositions comprising thereof
HU211935A9 (en) Modified polypeptide
ZA9106646B (en) Novel isocarbostiryl compounds and anti-tumor use thereof
ZW4891A1 (en) Polypeptides

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)